<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><front><journal-meta><journal-id journal-id-type="nlm-ta">Orthop J Sports Med</journal-id><journal-id journal-id-type="iso-abbrev">Orthop J Sports Med</journal-id><journal-id journal-id-type="publisher-id">OJS</journal-id><journal-id journal-id-type="hwp">spojs</journal-id><journal-title-group><journal-title>Orthopaedic Journal of Sports Medicine</journal-title></journal-title-group><issn pub-type="epub">2325-9671</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage CA: Los Angeles, CA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4595873</article-id><article-id pub-id-type="doi">10.1177/2325967114S00240</article-id><article-id pub-id-type="publisher-id">10.1177_2325967114S00240</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Holguin</surname><given-names>Esteban</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1-2325967114S00240">1</xref></contrib></contrib-group><aff id="aff1-2325967114S00240"><label>1</label>Hospital Metropolitano de Quito, Quito, Pichincha, Ecuador</aff><pub-date pub-type="epub"><day>5</day><month>1</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2014</year></pub-date><volume>2</volume><issue>4 Suppl</issue><issue-title>AAA 2014 International Meeting Abstracts</issue-title><elocation-id>2325967114S00240</elocation-id><permissions><copyright-statement>© The Author(s) 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For reprints and permission queries, please visit SAGE’s Web site at <ext-link ext-link-type="uri" xlink:href="http://www.sagepub.com/journalsPermissions.nav">http://www.sagepub.com/journalsPermissions.nav</ext-link>.</license-p></license></permissions><abstract><sec><title><offsets xml_i="2994" xml_f="3005" txt_i="11" txt_f="22">Objectives:</offsets></title><p><offsets xml_i="3016" xml_f="3167" txt_i="23" txt_f="174">To determine and compare the effects of autologous platelet rich plasma (PRP) and hyaluronic acid (HA) for the treatment of osteoarthritis of the knee.</offsets></p></sec><sec><title><offsets xml_i="3189" xml_f="3197" txt_i="176" txt_f="184">Methods:</offsets></title><p><offsets xml_i="3208" xml_f="3938" txt_i="185" txt_f="915">This prospective study included 150 patients affected by severe osteoarthritis of the knee. Gonarthrosis was graded using the Kellgren-Lawrence and Albhack radiographic classification scale. 150 patients were randomized into 2 study groups .In the PRP group (n=55) three intraarticular injection were applied andthe control group (n=55) received 3 intra-articular injections of high molecular weight HA. An unblinded physician performed infiltration once a week for 3 weeks into the knee affected by clinically relevant gonarthrosis (in both groups). All patients were evaluated with the Western Ontario and McMaster (WOMAC) score and visual pain scale before the infiltration and at 3, 6, and 12 months after the first injection.</offsets></p></sec><sec><title><offsets xml_i="3960" xml_f="3968" txt_i="917" txt_f="925">Results:</offsets></title><p><offsets xml_i="3979" xml_f="4334" txt_i="926" txt_f="1281">No severe adverse events was observed. Statistically significant better results in the WOMAC score and visual pain scale was determined in PRP group than HA group at 3 months and 6 months follow up. The cost of the application for the PRP group was lower than that of the HA group.At 12 months' of follow-up, PRP and HA treatments offered similar results.</offsets></p></sec><sec><title><offsets xml_i="4356" xml_f="4367" txt_i="1283" txt_f="1294">Conclusion:</offsets></title><p><offsets xml_i="4378" xml_f="4577" txt_i="1295" txt_f="1494">The results of this study have shown the application of autologousPRP to be a safe, effective and low-cost method for treating OA tan HA. However, further studies are required for a more clear result</offsets></p></sec></abstract><custom-meta-group><custom-meta><meta-name>edited-state</meta-name><meta-value>corrected-proof</meta-value></custom-meta></custom-meta-group></article-meta></front></article>